Google News
logo
Daily Current Affairs
Biological E vaccine has received DGCI approval to conduct phase 2/3 trials on children. What is the name of its COVID vaccine candidate?
A)
GSK
B)
J&J
C)
Corbevax
D)
Novavax

Correct Answer :   Corbevax


After the Drugs Controller General of India (DCGI) on September 2, 2021 approved second homegrown Zydus Cadila’s three-dose Covid-19 DNA vaccine for emergency use in adults and children aged 12 years and above, Hyderabad-based Biological E Limited has also been given the approval to conduct phase 2/3 clinical trials of its vaccine on children aged between 5 and 18 years with certain conditions.
 
 
What are the phases of approval?
 
The vaccine’s phase 2 and 3 clinical trials are conducted as per the approved protocol titled 'A  Prospective, Randomised, Double-blind, Placebo-controlled, Phase-2/3 Study to Evaluate Safety, Reactogenicity, Tolerability and Immunogenicity of Corbevax Vaccine in Children and Adolescents', as per the news agency PTI.

Published On : September 2, 2021
Advertisement